Orvos & Home Healthcare
Home health organizations are already reaching patients where many important healthcare gaps exist—the home. Orvos Healthcare can supplement that existing care regimen by enabling trained home health personnel to capture retinal images during a scheduled patient visit, while Orvos provides the physician interpretation, clinical findings, and recommended follow-up. This allows the home health organization to add diabetic eye screening without requiring the patient to travel to an ophthalmologist or schedule another appointment. That access is particularly important because CDC reports that 60% of people with diabetes do not receive an annual eye exam, despite diabetic retinopathy being a major cause of preventable vision loss.
For patients, the model creates a more comprehensive approach to diabetes management. The home health team can continue its existing clinical services while adding retinal screening to identify signs of diabetic retinopathy and potentially other ocular abnormalities that warrant further evaluation. When abnormalities are identified, the patient can be directed into the appropriate eye-care pathway earlier, rather than waiting until vision symptoms develop. CDC emphasizes that early detection is important because diabetic retinopathy may progress before a patient notices symptoms.
In a 2023 study, MedPAC found that 34.1% of Medicare FFS beneficiaries receiving home health had diabetes. That equates to a population of 1 out of every 3 or roughly 900,000 patients in home health have diabetes.
Through Orvo's partnership we have the ability to ensure those patients are getting the screening they require.
In a 2023 study, MedPAC found that 34.1% of Medicare FFS beneficiaries receiving home health had diabetes. That equates to a population of 1 out of every 3 or roughly 900,000 patients in home health have diabetes.
Through Orvo's partnership we have the ability to ensure those patients are getting the screening they require.